CSPG4P11: A Drug Target / Disease Biomarker (G100631254)

Target Name: CSPG4P11

NCBI ID: G100631254

CSPG4P11

Other Name(s): chondroitin sulfate proteoglycan 4 pseudogene 11 | Chondroitin sulfate proteoglycan 4 pseudogene 11

CSPG4P11: A Drug Target / Disease Biomarker

CSPG4P11 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the CSPG4 family, which includes several similar proteins that play important roles in cellular signaling and inflammation. One of the key functions of CSPG4P11 is its role in the regulation of inflammation, and it is thought to be involved in the development and progression of a number of diseases, including cancer.

The CSPG4P11 protein is composed of 11 amino acid residues and has a calculated molecular weight of 13.9 kDa. It is expressed in a variety of tissues, including the brain, heart, and kidneys, and is also found in the placenta and testes. It is thought to be involved in the regulation of cellular signaling pathways, including the TGF-β pathway, which is involved in the regulation of cell growth, differentiation, and inflammation.

One of the key functions of CSPG4P11 is its role in the regulation of inflammation. It is thought to be involved in the development and progression of a number of diseases, including cancer. For example, studies have shown that CSPG4P11 is expressed in a variety of tissues that are affected by cancer, and that it is involved in the regulation of cellular signaling pathways that are commonly associated with cancer.

In addition to its role in the regulation of inflammation, CSPG4P11 is also thought to be involved in the regulation of cellular signaling pathways that are important for normal cellular function. For example, it is involved in the regulation of the Wnt signaling pathway, which is involved in the development and maintenance of tissues in the body, and in the regulation of theNotch signaling pathway, which is involved in the regulation of cell growth and differentiation.

The CSPG4P11 protein is also thought to be involved in the regulation of cellular signaling pathways that are important for the development and progression of diseases. For example, studies have shown that CSPG4P11 is involved in the regulation of the NF-kappa-B signaling pathway, which is involved in the regulation of inflammation and immune responses.

In conclusion, CSPG4P11 is a protein that is expressed in various tissues of the body and is involved in a number of cellular signaling pathways. It is thought to be involved in the regulation of inflammation, and in the regulation of cellular signaling pathways that are important for normal cellular function and the development and progression of diseases. Further research is needed to fully understand the role of CSPG4P11 in these processes and to determine its potential as a drug target or biomarker.

Protein Name: Chondroitin Sulfate Proteoglycan 4 Pseudogene 11

The "CSPG4P11 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CSPG4P11 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets